After waking up from the procedure, he told me he could take full breaths for the first time in years,” Dr. Mark Sigler said ...

AstraZeneca’s respiratory and immunology portfolio is driving significant growth, with R&I assets forecasted to account for ...

According to Nice, osimertinib can help stop cancer from returning after surgery by targeting cells that have specific ...

Ensifentrine is a promising supplementary therapeutic option in the management of chronic obstructive pulmonary disease (COPD), according to systematic review and meta-analysis findings published in ...

In separate, live virtual events, Vincent K. Lam, MD, and Chul Kim, MD, MPH, discuss molecular assays and treatment options ...

Integrated care involving medication and intensive counseling showed effectiveness for smoking cessation among adults ...

Nov. 27, 2024 — A recent trial finds an injection given during some asthma and COPD attacks is more effective than the current treatment of steroid tablets, reducing the need for further ...

Shares in Keros Therapeutics fell sharply Wednesday morning after it said it halted trials of its treatment for pulmonary hypertension after finding adverse health effects in patients trialing the ...

During a Community Case Forum event in partnership with the Medical Oncology Association of Southern California, Edward S.

MRI of inhaled perfluoropropane can assess regional lung ventilation and monitor improvements in response to medication ...

For the first time Australian researchers have identified how exposure to smoking may cause a deadly lung disease that claims ...